Vivek Natarajan, Research Lead, Google Health AI, Google, San Francisco, CA, discusses the potential applications of artificial intelligence (AI) to address challenges in diagnosing and treating neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. He emphasizes the potential for AI systems to identify early biomarkers and improve clinical trials, potentially accelerating drug discovery and enhancing patient care. This interview took place at the Shaping the Future of Medicine (STFOM 2024) congress held in Leipzig, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.